brief: Poland lifescience ecosystem

Poland is growing faster then other EU countries and there is good base to build a winning life science cluster. ±€5 bil in pharma/y, ±€1bil in medical devices/y, 8000 local life science companies, about 1000 Hospitals and 20k clinics or 6H beds /000 (2x than the USA and 1.5x then CH) is a good start. Bioengineering MSc degrees are issued in english in more than one University and this adds more skills and specialized staff in the market; however all this needs a boost as there is yet not enough concentration of interconnected businesses, free contractors, associated institutions and startup wins to evidence a clear self regeneration. Some of Poland new round of grants (±€5 bil /year in development) could help if intentionally directed to this sector and partially adapted to the special requirements life science early stage projects need to achieve commercialization.

Eliza Kruczkowska, Shimi Azaria, and David G. Vita; moderator: Roi Ben Daniel.

Eliza Kruczkowska, Shimi Azaria, and David G. Vita; moderator: Roi Ben Daniel.

Poland’s Emerging Biotech Sector: The Time Is Right for Startups